Gara Jalqabaatti › Dukkana Bladder › California › San Francisco
Qorannoo klinikaalii Dukkana Bladder San Francisco, CA keessatti
Qorannoo 13 Dukkana Bladder f San Francisco fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
Namoota walitti qabaa jiraSadarkaa 1/2
- UCSF Medical Center at Mission Bay ( Site 5044), San Francisco
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- University of California, San Francisco, San Francisco
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
Namoota walitti qabaa jiraSadarkaa 1
- University of California, San Francisco, San Francisco
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Namoota walitti qabaa jiraSadarkaa 3
- UCSF Medical Center at Mission Bay, San Francisco
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Namoota walitti qabaa jiraSadarkaa 1
- UCSF Medical center Parnassus, San Francisco
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Namoota walitti qabaa jiraSadarkaa 2/3
- Pacific Hematology Oncology Associates, San Francisco
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Namoota walitti qabaa jiraSadarkaa 2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Namoota walitti qabaa jiraSadarkaa 2
- UCSF Cancer Center MZ Phlebotomy, San Francisco
- UCSF Mount Zion Phlebotomy, San Francisco
- UCSF Parnassus Phlebotomy, San Francisco
- fi 3 dabalataa
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, San Francisco
Predicting BCG Response
Namoota walitti qabaa jiraQorannoo ilaalaa
- UCSF, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- University of California San Francisco, San Francisco
Blue Light Cystoscopy With Cysview® Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, San Francisco
Qorannoo Dukkana Bladder magaalota biroo keessatti
- New York City, NYQorannoo 35
- Nashville, TNQorannoo 31
- Houston, TXQorannoo 31
- Dallas, TXQorannoo 27
- Washington, DCQorannoo 26
- Boston, MAQorannoo 26
- Baltimore, MDQorannoo 24
- Los Angeles, CAQorannoo 24
- St. Louis, MOQorannoo 22
- Seattle, WAQorannoo 21
- Chicago, ILQorannoo 21
- Philadelphia, PAQorannoo 21
Qorannoo biroo San Francisco keessatti
- Kansarii ProstateQorannoo 45
- Saree OljooQorannoo 43
- Kansara Qara'a Non-Small CellQorannoo 36
- Saree (Gosoota Hunda)Qorannoo 35
- Cufama OnneeQorannoo 29
- Kansara MetastatikiiQorannoo 28
- Dhibee QaraQorannoo 22
- MelanomaQorannoo 22
- Kansarii PancreasQorannoo 20
- Kansarii OvariiQorannoo 19
- Kansarii ColorectalQorannoo 18
- Dhibee Onneessaa fi DhiigaQorannoo 18
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.